Prion protein interactions with nucleic acid: Possible models for prion disease and prion function

Neurochemical Research

Volumn 28, Issue 6, 2003, Pages 955-963

  Grossman, Abraham ^a   Zeiler, Brian ^a   Sapirstein, Victor ^b  

^a Q RNA Inc   (United States)

^b SerOptix Inc   (United States)

Author keywords

BSE; DNA protein interactions; PrP; RNA; RNA protein interactions

Indexed keywords

CHAPERONE; NUCLEIC ACID; PRION PROTEIN;

ANIMAL MODEL; CATALYST; CHEMICAL MODIFICATION; DISEASE COURSE; DISEASE TRANSMISSION; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SCRAPIE;

ANIMALS; DNA; HUMANS; PRION DISEASES; PRIONS; RNA; SCRAPIE;

ANIMALIA;

EID: 0037409731     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023215207981     Document Type: Review

References (90)

1. Prusiner, S. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-144.
2. Prusiner, S., Scott, M., DeArmond, S., and Cohen, F. 1998. Prion protein biology. Cell 93:337-348.
3. Weissman, C. 1994. Molecular biology of prion diseases. Trends Cell. Biol. 4:10-14.
4. Merz, P., Somerville, R., Wisniewski, H., and Iqbal, K. 1981. Abnormal fibrils from scrapie-infected brain. Acta. Neuropathol. (Berl.) 54:63-74.
5. Prusiner, S. 1999. An introduction to prion biology and diseases. Pages 1-66, in Prusiner, S. (eds.), Prion Biology and Diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
6. Caughey, B. and Chesebro, B. 1997. Prion protein and the transmissible spongiform encephalopathies. Trends Cell. Biol. 7:56-62.
7. Scott, M., Foster, D., Mirenda, C., Groth, D., Coufal, F., Walchi, M., Torcia, M., Carlson, G., DeArmond, S., Westaway, D. et al. 1989. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59:847-857.
8. Telling, G., Scott, M., Mastrianni, J., Gabizon, R., Torcia, M., Cohen, F., DeArmond, S., and Prusiner, S. 1995. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83:79-90.
9. Oesch, B., Westaway, D., Walchli, M., McKinley, M., Kent, S., Aebersold, R., Barry, R., Tempst, P., Teplow, D., and Hood, L. 1985. A cellular gene encodes scrapie PrP27-30 protein. Cell 40:735-746.
10. Robakis, N., Sawh, P., Wolfe, G., Rubenstein, R., Carp, R., and Innis, M. 1986. Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues. Proc. Natl. Acad. Sci. USA 83:6377-6381.
11. Basler, K., Oesch, B., Scott, M., Westaway, D., Walchi, M., Groth, D., McKinley, M., Prusiner, S., and Weissmann, C. 1986. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46:417-428.
12. Weissman, C. 1991. A 'unified' theory of prion propagation. Nature 352:679-683.
13. Weissmann, C., Enari, M., Klöhn, P.-C., Rossi, D., and Flechsig, E. 2002. Transmission of prions. J. Infect. Dis. 186: S157-S165.
14. Aguzzi, A. and Weissmann, C. 2002. Prion research: The next frontiers. Nature 389:795-798.
15. Borman, S. 1998. Prion research accelerates. Chem. Eng. News 76:22-29.
16. Bolton, D. and Bendheim, P. 1988. A modified host protein model of scrapie. Ciba Found. Symp. 135:164-181.
17. Prusiner, S. 1999. Development of the prion concept. Pages 67-112, in Prusiner, S. (eds.), Prion Biology and Diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
18. Kellings, K., Meyer, N., Mirenda, C., Prusiner, S., and Riesner, D. 1992. Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis. J. Gen. Virol. 73:1025-1029.
19. Riesner, D., Kellings, K., Wiese, U., Wulfert, M., Mirenda, C., and Prusiner, S. 1993. Prions and nucleic acids: Search for "residual" nucleic acids and screening for mutations in the PrP-gene. Dev. Biol. Stand. 80:173-181.
20. Chesebro, B. 1998. BSE and prions: Uncertainties about the agent. Science 279:42-43.
21. Stahl, N., Baldwin, M., Teplow, D., Hood, L., Gibson, B., Burlingame, A., and Prusiner, S. 1993. Structural studies of the scrapie prion protein using mass spectroscopy and amino acid sequencing. Biochemistry 32:1991-2002.
22. Appel, T., Dumpitak, C., Matthiesen, U., and Riesner, D. 1999. Prion rods contain an inert polysaccharide scaffold. Biol. Chem. 380:1295-1306.
23. Narang, H. 1998. Evidence that single-stranded DNA wrapped around the tubulofilamentous particles termed "nemaviruses" is the genome of the scrapie agent. Res. Virol. 149:375-382.
24. Cohen, F. and Prusiner, S. 1999. Structural studies of prion proteins. Pages 191-228, in Prusiner, S. (eds.), Prion Biology and Disease. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
25. Hill, A., Antoniou, M., and Collinge, J. 1999. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 80:11-14.
26. Prusiner, S., Groth, D., Serban, A., Stahl, N., and Gabizon, R. 1993. Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc. Natl. Acad. Sci. USA 90:2793-2797.
27. Shaked, G., Fridlander, G., Meiner, Z., Taraboulos, A., and Gabizon, R. 1999. Protease-resistant and detergent-insoluble prion protein is not neccessarily associated with prion infectivity. J. Biol. Chem. 274:17981-17986.
28. Narang, H. 1992. Relationship of protease-resistant protein, scrapie-associated fibrils and tubulofilamentous particles to the agent of spongiform encephalopathies. Res. Virol. 143:381-386.
29. Saborio, G., Soto, C., Kascsak, R., Levy, E., Kascsak, R., Harris, D., and Frangione, B. 1999. Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone. Biochem. Biophys. Res. Com. 258: 470-475.
30. Barrette, I., Poisson, G., Gendron, P., and Major, F. 2001. Pseudoknots in prion protein mRNAs confirmed by comparative sequence analysis and pattern searching. Nucleic Acids Res. 29:753-758.
31. Thanaraj, T. and Argos, P. 1996. Protein secondary structural types are differentially coded on messenger RNA. Protein Sci. 5:1973-1983.
32. Hegde, R., Mastrianni, J., Scott, M., DeFea, K., Tremblay, P., Torchia, M., DeArmond, Prusiner, S., and Lingappa, V. 1998. A transmembrane form of the prion protein in neurodegenerative disease. Science 279:827-834.
33. Hölscher, C., Bach, U., and Dobberstein, B. 2001. Prion protein contains a second endoplasmic reticulum targeting signal sequence located at its C terminus. J. Biol. Chem. 276:13388-13394.
34. Baron, G., Wehrly, K., Dorward, D., Chesebro, B., and Caughey, B. 2002. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO 21:1031-1040.
35. Prusiner, S. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-13383.
36. Jeffrey, M., Goodsir, C., Bruce, M., McBride, P., and Fraser, J. 1997. In vivo toxicity of prion protein in murine scrapie: ultrastructural and immunogold studies. Neuropathol. Appl. Neurobiol. 23:93-1001.
37. Jeffrey, M., Goodsir, C., Bruce, M., McBride, P., Scott, J., and Halliday, W. 1992. Infection specific prion protein (PrP) accumulates on neuronal plasmalemma in scrapie infected mice. Neurosci. Lett. 147:106-109.
38. Borchelt, D., Taraboulos, A., and Prusiner, S. 1992. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J. Biol. Chem. 267:16188-16199.
39. Caughey, B., Raymond, G., Ernst, D., and Race, R. 1991. N-Terminal truncation of the scrapie-associated form of PrP by lysosomalprotease(s): Implications regarding the site of conversion to the protease-resistant state. J. Virol. 65:6597-6603.
40. McKinley, M., Taraboulos, A., Kenaga, L., Serban, D., Stieber, A., DeArmond, S., Prusiner, S., and Gonatas, N. 1991. Ultrastuctural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab. Invest. 65:622-630.
41. Brown, D., Qin, K., Herms, J., Madlung, A., Manson, J., Strome, R., Fraser, P., Kruck, T., von Bohlen, A., Schulz-Schaeffer, W. et al. 2002. The cellular prion protein binds copper in vivo. Nature 390:684-687.
42. Jackson, G., Murray, I., Hosszu, L., Gibbs, N., Waltho, J., Clarke, A., and Collinge, J. 2001. Location and properties of metal-binding sites on the human prion protein. Proc. Natl. Acad. Sci. USA 98:8531-8535.
43. Hornshaw, M., McDermott, J., and Candy, J. 1995. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Bioc. Biophys. Res. Commun. 207:621-629.
44. Jobling, M., Huang, X., Stewart, L., Barnham, K., Curtain, C., Volitakis, I., Perugini, M., White, A., Cherny, R., Masters, C. et al. 2001. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. Biochemistry 40:8073-8084.
45. Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugliani, O., and Tagliavini, F. 1993. Neurotoxicity of a prion protein fragment. Nature 362:543-546.
46. Brown, D., Schmidt, B., and Kretzschmar, H. 1996. Role of microglia and host protein in neurotoxicity of a prion protein fragment. Nature 380:345-347.
47. Korth, C., May, B., Cohen, F., and Prusiner, S. 2001. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci. USA 98:9836-9841.
48. Forloni, G., Iussich, S., Awan, T., Colombo, L., Angeretti, N., Girola, L., Bertani, I., Poli, G., Caramelli, M., Bruzzone, M. et al. 2002. Tetracyclines affect prion infectivity. Proc. Natl. Acad. Sci. USA 99:10849-10854.
49. Kuner, P., Bohrmann, B., Tjernberg, L., Näslund, J., Huber, G., Celenk, S., Grüninger-Leitch, F., Richards, J., Jakob-Rætne, R., Kemp, J. et al. 2000. Controlling polymerization of β-amyloid and prion-derived peptides with synthetic small molecule ligands. J. Biol. Chem. 275:1673-1678.
50. Schmitt-Ulms, G., Legname, G., Baldwin, M., Ball, H., Bradon, N., Bosque, P., Crossin, K., Edelman, G., DeArmond, S., Cohen, F. et al. 2001. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J. Mol. Biol. 314:1209-1225.
51. Klein, T., Kirsch, D., Kaufmann, R., and Riesner, D. 1998. Prion rods contain small amounts of two host sphingolipids as revealed by thin-layer chromatography and mass spectrometry. Biol. Chem. 379:655-666.
52. Shaked, G., Meiner, Z., Avraham, I., Taraboulos, A., and Gabizon, R. 2001. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods. J. Biol. Chem. 276:14321-14328.
53. Cordeiro, Y., Machado, F., Juliano, L., Aparecida Juliano, M., Brentani, R., Foguel, D., and Silva, J. 2001. DNA converts cellular prion protein into the beta-Sheet conformation and inhibits prion peptide aggregation. J. Biol. Chem. 276: 49400-49409.
54. Gabus, C., Derrington, E., Leblanc, P., Chainerman, J., Dormont, D., Swietnicki, W., Morillas, M., Surewicz, W., Marc, D., Nandi, P. et al. 2001. The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1 ribonucleic acid. J. Biol. Chem. 276: 19301-19309.
55. Gabus, C., Auxilien, S., Pechoux, C., Dormont, D., Swietnicki, W., Morillas, M., Surewicz, W., Nandi, P., and Darlix, J. 2001. The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. J. Mol. Biol. 307:1011-1021.
56. Nandi, P. 1998. Polymerization of human prion peptide HuPrP 106-126 to amyloid in nucleic acid solution. Arch. Virol. 143:1251-1263.
57. Nandi, P. and Leclerc, E. 1999. Polymerization of murine recombinant prion protein in nucleic acid solution. Arch. Virol. 144:1751-1763.
58. Weiss, S., Proske, D., Neumann, M., Groschup, M., Kretzschmar, H., Famulok, M., and Winnacker, E. 1997. RNA aptamers specifically interact with the prion protein PrP. J. Virol. 71:8790-9797.
59. Zeiler, B., Adler, V., Kryukov, V., and Grossman, A. 2002. Concentration and removal of prion proteins from biological solutions. Biotech. Appl. Biochem., 37:173-182.
60. Carp, R., Meeker, H., Caruso, V., and Sersen, E. 1999. Scrapie strain-specific interactions with endogenous murine leukemia virus. J. Gen. Virol. 80:5-10.
61. Carp, R., Meeker, H., Sersen, E., and Kozlowski, P. 1998. Analysis of the incubation periods, induction of obesity and histopathological changes in senescence-prone and senescenceresistant mice infected with various scrapie strains. J. Gen. Virol. 79:2863-2869.
62. Rymer, D. and Good, T. 2000. The role of prion peptide structure and aggregation in toxicity and membrane binding. J. Neurochem. 75:2536-2545.
63. Thellung, S., Florio, T., Corsaro, A., Arena, S., Merlino, M., Salmona, M., Tagliavini, F., Bugiani, O., Forloni, G., and Schettini, G. 2000. The role of prion peptide structure and aggregation in toxicity and membrane binding. Int. J. Dev. Neursci. 18:481-492.
64. Donne, D., Viles, J., Groth, D., Mehlhorn, I., James, T., Cohen, F., Prusiner, S., Wright, P., and Dyson, H. 1997. Structure of the recombinant full-length hamster prion protein PrP(29-231): The N terminus is highly flexible. Proc. Natl. Acad. Sci. USA 94:13452-13457.
65. Zhang, H., Kaneko, K., Nguyen, J., Livshits, T., Baldwin, M., Cohen, F., James, T., and Prusiner, S. 1995. Conformational transitions in peptides containing two putative α-helices of the prion protein. J. Mol. Biol. 250:514-526.
66. Huang, Z., Gabriel, J.-M., Baldwin, M., Fletterick, R., Prusiner, S., and Cohen, F. 1994. Proposed three-dimensional structure for the cellular prion protein. Proc. Natl. Acad. Sci. USA 91:7139-7143.
67. Harrison, P., Bamborough, P., Daggett, V., Prusiner, S., and Cohen, F. 1997. The prion folding problem. Curr. Opin. Struct. Biol. 7:53-59.
68. Hope, J., Shearman, M., Baxter, H., Chong, A., Kelly, S., and Price, N. 1996. Cytotoxicity of prion protein peptide (PrP106126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35. Neurodegeneration. 5: 1-11.
69. Nandi, P. 1997. Interaction of prion peptide HuPrP106-126 with nucleic acid. Arch. Virol. 142:2537-2545.
70. Tagliavini, F., Prelli, F., Verga, L., Giaccone, G., Sarma, R., Gorevic, P., Ghetti, B., Passerini, F., Ghibaudi, E., Forloni, G., et al. 1993. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA 90:9678-9682.
71. Selvaggini, C., De Gioia, L., Ghibaudi, E., Diomede, L., Passerini, F., Forloni, G., Bugiani, O., Tagliavini, F., and Salmona, M. 1993. Molecular characteristics of a proteaseresistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Res. Commun. 194:1380-1386.
72. Li, R., Liu, T., Wong, B., Pan, T., Morillas, M., Swietnicki, W., O'Rourke, K., Gambetti, P., Surewicz, W., and Sy, M. 2000. Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J. Mol. Biol. 301:567-573.
73. Nandi, P. and Sizaret, P. 2001. Murine recombinant prion protein induces ordered aggregation of linear nucleic acids to condensed globular structures. Arch. Virol. 146:327-345.
74. Darlix, J., Lapadat-Tapolsky, M., de Rocquigny, H., and Roques, B. 1995. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 254:523-537.
75. Bueler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H., DeArmond, S., Prusiner, S., Aguet, M., and Weissmann, C. 1992. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-582.
76. Jackson, G. and Clarke, A. 2000. Mammalian prion proteins. Curr. Opin. Struct. Biol. 10:69-74.
77. Derrington, E., Gabus, C., Leblanc, P., Chnaidermann, J., Grave, L., Dormont, D., Swietnicki, W., Morillas, M., Marck, D., Nandi, P. et al. 2002. PrPC has nucleic acid chaperoning properties similar to the nucleocapsid protein of HIV-1. C. R. Acad. Sci. 325:17-23.
78. Sheng, N. and Erickson-Viitanen, S. 1994. Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease in RNA dependent. J. Virol. 68:6207-6214.
79. Kaneko, K., Zulianello, L., Scott, M., Cooper, C., Wallace, A., James, T., Cohen, F., and Prusiner, S. 1997. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie protein propagation. Proc. Natl. Acad. Sci. USA 94:10069-10074.
80. Warwicker, J. 2000. Modeling a prion protein dimer: Predictions for fibril formation. Biochem. Biophys. Res. Commun. 278:646-652.
81. C) not observed with recombinant PrP. J. Biol. Chem. 275:38081-38087.
82. Knaus, K., Morillas, M., Swietnicki, W., Malone, M., Surewicz, W., and Yee, V. 2001. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat. Struct. Biol. 8:770-774.
83. Hermann, T. and Patel, D. 2000. Adaptive recognition by nucleic acid aptamers. Science 287:820-825.
84. Hermann, T. and Westhof, E. 1999. Non-Watson-Crick base pairs in RNA-protein recognition. Chem. Biol. 6:R335-R343.
85. Puglisi, J. and Williamson, J. 1999. RNA Interaction with small ligands and peptides. Pages in Cech, T. and Atkins, J. (eds.), The RNA World. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 403-425.
86. Wisniewski, H., Bruce, M., and Fraser, H. 1975. Infectious etiology of neuritic (senile) plaques in mice. Science 190:1108-1110.
87. Ylera, F., Lurz, R., Erdmann, V., and Fürste, J. 2002. Selection of RNA aptamers to the Alzheimer's disease amyloid peptide. Biochem. Biophys. Res. Commun. 290:1583-1588.
88. Ginsberg, S., Crino, P., Hemby, S., Weingarten, J., Lee, V., Eberwine, J., and Trojanowski, J. 1999. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques. Ann. Neurol. 45:174-181.
89. Marcinkiewiczs, M. 2002. BetaAPP and furin mRNA concentrates in immature senile plaques in the brain of Alzheimer patients. J. Neuropathol. Exp. Neurol, 61:815-829.
90. Kampers, T., Friedhoff, P., Biernat, J., Mandelkow, E., and Mandelkow, E. 1996. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett. 399:344-349.